Namibia’s president to undergo treatment after ‘cancerous cells’ found
Al Jazeera
Hage Geingob, 82, will continue to carry out his presidential duties while seeking treatment, his office said.
Namibian President Hage Geingob will start treatment for cancer after routine medical checkups led to the detection of “cancerous cells”, his office has said.
In a statement from the Namibian Presidency on Friday, it said that “as part of regular annual medical examinations” the 82-year-old leader had a colonoscopy and a gastroscopy on January 8, followed by a biopsy.
“The results revealed cancerous cells,” the statement said.
“On the advice of the medical team, President Geingob will undertake appropriate medical treatment to deal with the cancerous cells,” it added.
Geingob’s office gave no more details on his diagnosis but said he would continue working.
UN health agency says its decision is ‘based on the rising number and continuing geographic spread of cases.’
In a new interview, the scandal-plagued Gaetz reaffirmed his commitment to being a member of Trump’s ‘America First army’.
Legislators greenlight reforms giving more authority to Daniel Ortega and Rosario Murillo, accused of stifling dissent.
Pep Guardiola leads Man City out for the first time since signing a two-year extension when Tottenham visit on Saturday.
Five healthcare workers killed in Israeli strikes in southern Lebanon, Ministry of Public Health says.
Vulnerable nations are seeking $1.3 trillion annually to deal with the damage caused by climate change and to adapt.
The city’s southern suburbs have been hit repeatedly in recent months
New York judge cancels a sentencing hearing previously scheduled for November 26 without setting a new date.
Many Haitian children face the stark choice of joining a gang or suffering from violence, poverty and hunger engulfing them.
Tapped to lead the Justice Department, Bondi is a former Florida attorney general and longtime Trump supporter.
The arrest warrants against Netanyahu and Gallant could lead to countries rethinking arms deals with Israel, experts say